Don Vince-Cruz

IrishAngels is a Notre Dame inspired angel investing group for experienced operators, executives, and founders who want to invest thoughtfully in early-stage companies and stay meaningfully involved beyond the check. Our investors share a common foundation through the University of Notre Dame and a belief that early-stage investing works best when capital and community come together. We invest primarily at the seed stage across B2B and consumer technology, partnering closely with founders and co-investors we respect. Since 2012, IrishAngels has deployed over $65 million into more than 100 companies. More importantly, we’ve built an active, engaged community of over 250 angels who bring operating experience, pattern recognition, and long-term perspective to the companies we support. IrishAngels aims to be a trusted partner to founders and a credible co-investor to the broader venture ecosystem. Headquartered in Chicago, with members across the U.S.

At Kite, a Gilead Company, our singular focus is achieving cures with cell therapy. Our goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit. Since 2009, Kite has been at the forefront of cancer immunotherapy. Today, we are proud to be the leader in engineered T cell therapy for hematologic malignancies, but we recognize that this is just the beginning. Patients are at the heart of our focus on the cure, which is why we are committed to pursuing cell therapy as a transformative treatment option for as many patients as possible who may benefit. Unlike traditional pharmaceutical manufacturing, our therapies are not created on an assembly line. Cell therapy specialists at our manufacturing facilities reengineer a patient’s own immune cells to attack and fight their cancer cells — one patient at a time. That sense of connection to the people we serve motivates us daily at Kite. Our corporate headquarters are located in Santa Monica, California, and we have dedicated cell therapy manufacturing facilities in California, Maryland and the Netherlands. If you’re passionate about bringing the curative potential of cell therapy to more eligible patients, let’s talk. See our community guidelines: http://bit.ly/2DznMNw

IrishAngels is a Notre Dame inspired angel investing group for experienced operators, executives, and founders who want to invest thoughtfully in early-stage companies and stay meaningfully involved beyond the check. Our investors share a common foundation through the University of Notre Dame and a belief that early-stage investing works best when capital and community come together. We invest primarily at the seed stage across B2B and consumer technology, partnering closely with founders and co-investors we respect. Since 2012, IrishAngels has deployed over $65 million into more than 100 companies. More importantly, we’ve built an active, engaged community of over 250 angels who bring operating experience, pattern recognition, and long-term perspective to the companies we support. IrishAngels aims to be a trusted partner to founders and a credible co-investor to the broader venture ecosystem. Headquartered in Chicago, with members across the U.S.